• Research
  • About
  • Experts
Carnegie India logoCarnegie lettermark logo
AI
{
  "authors": [
    "Shruti Sharma"
  ],
  "type": "commentary",
  "centerAffiliationAll": "",
  "centers": [
    "Carnegie Endowment for International Peace",
    "Carnegie India"
  ],
  "collections": [
    "Coronavirus"
  ],
  "englishNewsletterAll": "",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie India",
  "programAffiliation": "",
  "programs": [],
  "projects": [
    "Technology and Society"
  ],
  "regions": [
    "South Asia",
    "India",
    "East Asia",
    "China"
  ],
  "topics": [
    "Domestic Politics",
    "Technology"
  ]
}

Source: Getty

Commentary
Carnegie India

Across the Border from China, How Should India Prepare for the Coronavirus?

India’s teeming population, rickety public health system, and shared border with China make it vulnerable to the deadly coronavirus. How should the country prepare?

Link Copied
By Shruti Sharma
Published on Jan 28, 2020
Project hero Image

Project

Technology and Society

This program focuses on five sets of imperatives: data, strategic technologies, emerging technologies, digital public infrastructure, and strategic partnerships.

Learn More

The December 2019 outbreak of the coronavirus originated in a city in central China called Wuhan, and the strain has now spread to more than ten countries. In China, over 4,500 people are known to be infected, and 106 have been reported dead; these numbers are rising rapidly every day. The global spread of this outbreak should serve as a wake-up call for governments around the world, particularly India, which not only shares a border with China and is densely populated but also has a fragile public health infrastructure.

Wuhan and several other Chinese cities have been quarantined to contain the disease. But amid the Chinese New Year celebrations, millions of people elsewhere in the country have been traveling, exacerbating the risk that the virus has continued to spread.

Since the Wuhan outbreak, India has taken some steps to ramp up its vigilance and preparedness. But it needs a stronger strategy to deal with any infections. So far, a travel advisory has been issued and at least twenty airports in major metropolitan areas have been instructed to screen passengers coming from China. Several laboratories under the Indian Council of Medical Research, including the National Institute of Virology, have been equipped to test samples of the virus. India’s Health Secretary has also told all states and union territories “to review their preparedness, identify gaps and strengthen core capacities needed to prepare for, detect, and respond to possible outbreaks.”

However, India’s efforts to prevent, detect, and respond to previous infections in remote impoverished areas have been hindered by weak or non-existent health systems. Poor transportation and communication networks, few skilled local health workers, and limited laboratory capacity have made it harder to stop the spread of disease in rural India. Other issues include poor interagency communication between animal and public health networks, inadequate involvement of private health practitioners, and suboptimal national reporting systems. These delay the recognition, diagnosis, and control of zoonotic infections (which may spread from animals to humans).

With more than 250 Indian students waiting anxiously to come back during the holiday season, and other potential visitors, the Indian Health Ministry should consider expanding capacity to more laboratories that can diagnose the new coronavirus. It should also focus on infection prevention and control measures. Such measures include quarantining patients, using personal protective equipment, and following decontamination strategies.

Since there is not yet an existing vaccine or drug available to counter this medical emergency, the number of fatalities is likely to increase globally. India should work with other interested countries to develop a vaccine or cure and ensure it has the domestic capacity to mass-produce any countermeasures once scientists have developed them. This may require relaxing restrictive regulations that otherwise hamper commercialization of pharma products in India. Such a move would improve India’s capacity to stop this pandemic threat and help the country become a global powerhouse for producing necessary drugs and vaccines.

While there have been no confirmed cases of the coronavirus in India so far, Delhi’s decision to evacuate the trapped Indian students in Wuhan increases the country’s vulnerability to the infection. India should therefore strengthen its capabilities to effectively prevent, detect, and respond to this looming threat.

Note: This piece has been updated to reflect the latest numbers as of January 28, 2020.

About the Author

Shruti Sharma

Former Associate Director, Fellow, and Chief Coordinator, Global Technology Summit, Technology and Society Program

Shruti Sharma was an associate director and a fellow with the Technology and Society Program at Carnegie India, where she is currently working on exploring the challenges and opportunities in leveraging biotechnology to improve public health capacity in India. Additionally, she is the Chief Coordinator of Carnegie India's Global Technology Summit.

    Recent Work

  • Article
    The India-United Kingdom Technology and Security Initiative: Ideas for Change
      • +1

      Rudra Chaudhuri, Tejas Bharadwaj, Konark Bhandari, …

  • Commentary
    The India-U.S. TRUST Initiative: A Resilient Pharma Supply Chain

      Shruti Sharma

Shruti Sharma
Former Associate Director, Fellow, and Chief Coordinator, Global Technology Summit, Technology and Society Program
Shruti Sharma
Domestic PoliticsTechnologySouth AsiaIndiaEast AsiaChina

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

  • Article
    India’s Oil Security Strategy: Structural Vulnerabilities and Strategic Choices

    This piece argues that the present Indian strategy, based on opportunistic diversification and utilization of limited strategic reserves, remains inadequate when confronting supply disruptions. It evaluates India’s options in the short, medium, and long terms.

      Vrinda Sahai

  • Article
    What Could a Reciprocal Defense Procurement Agreement Do for U.S.-India Ties?

    India and the United States are close to concluding a Reciprocal Defense Procurement Agreement (RDPA) that will allow firms from the two countries to sell to each other’s defense establishments more easily. While this may not remedy the specific grievances both sides may have regarding larger bilateral issues, an RDPA could restore some momentum, following the trade deal announcement.

      Konark Bhandari

  • Commentary
    India Signs the Pax Silica—A Counter to Pax Sinica?

    On the last day of the India AI Impact Summit, India signed Pax Silica, a U.S.-led declaration seemingly focused on semiconductors. While India’s accession to the same was not entirely unforeseen, becoming a signatory nation this quickly was not on the cards either.

      Konark Bhandari

  • Commentary
    The PSLV Setback: Restoring India’s Workhorse

    On January 12, 2026, India's "workhorse," the Polar Satellite Launch Vehicle, experienced a consecutive mission failure for the first time in its history. This commentary explores the implications of this incident on India’s space sector and how India can effectively address issues stemming from the incident.

      Tejas Bharadwaj

  • Commentary
    AI Adoption Journey for Population Scale

    Connecting real-world AI use cases across sectors such as health, education, agriculture, and livelihoods can help policymakers, innovators, and institutions align around a shared goal. This article looks at a framework ensuring that AI works for everyone.

      Shalini Kapoor, Tanvi Lall

Get more news and analysis from
Carnegie India
Carnegie India logo, white
Unit C-4, 5, 6, EdenparkShaheed Jeet Singh MargNew Delhi – 110016, IndiaPhone: 011-40078687
  • Research
  • About
  • Experts
  • Projects
  • Events
  • Contact
  • Careers
  • Privacy
  • For Media
Get more news and analysis from
Carnegie India
© 2026 Carnegie Endowment for International Peace. All rights reserved.